Oppenheimer Maintains Outperform Rating on UPS
Oppenheimer maintained its Outperform rating on United Parcel Service.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
20 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Oppenheimer Maintains Outperform Rating on Xylem, Keeps $135 Target
Oppenheimer maintained its Outperform rating on Xylem and a $135 price target. The target implies 45.4% upside from the Oct. 27 close of $92.86.
Oppenheimer Maintains Outperform Rating on Wave Life Sciences, Sets $29 Target
Oppenheimer maintained its Outperform rating on Wave Life Sciences and set a $29 price target. The note cited a 740.6% implied upside from the Oct. 27 close of $3.45.
Oppenheimer Maintains Outperform Rating on JFrog, Sets $125 Target
Oppenheimer maintained its Outperform rating on JFrog and a $125 price target. The target implies 24.4% upside from the Oct. 27 close of $100.46.
Oppenheimer Maintains Outperform Rating on Church & Dwight, Sets $120 Target
Oppenheimer maintained its Outperform rating on Church & Dwight and set a $120 price target. The target implies 14.3% upside from the Oct. 27 close of $105.01.
Oppenheimer Maintains Outperform Rating on Twilio, Keeps $325 Target
Oppenheimer maintained its Outperform rating on Twilio and a $325 price target. The target implies 25.6% upside from the Oct. 20 close of $258.69.
Oppenheimer Maintains Outperform Rating on Netflix, $80 Target
Oppenheimer maintained its Outperform rating and $80.00 price target. The target implies 16.5% upside from Netflix’s Oct. 20 close of $68.69.
Oppenheimer Maintains Outperform Rating on U.S. Bancorp, Sets $73 Target
Oppenheimer maintained its Outperform rating on U.S. Bancorp and a $73.00 price target. The target implies 27.2% upside from the Oct. 15 close of $57.39.
Oppenheimer Maintains Outperform Rating on PNC, Keeps $269 Target
Oppenheimer maintained its Outperform rating on PNC Financial Services Group and a $269 price target. The target implies 25.2% upside from the Oct. 15 close of $214.94.
Oppenheimer Maintains Outperform Rating on Builders FirstSource, $78 Target
Oppenheimer maintained its Outperform rating on Builders FirstSource and set a $78.00 price target. The target implies 45.3% upside from the Oct. 15 close of $53.68.
Oppenheimer Maintains Outperform Rating on Mueller Water Products, Sets $30 Target
Oppenheimer maintained its Outperform rating and $30 price target. The target implies 38.1% upside from Mueller Water Products’ Oct. 13 close of $21.73.
Oppenheimer Maintains Outperform Rating on DigitalOcean, Sets $220 Target
Oppenheimer maintained its Outperform rating on DigitalOcean and set a $220 price target. The target implies 71.6% upside from the Oct. 13 close of $128.21.
Oppenheimer Maintains Outperform Rating on ServiceNow, $165 Target
Oppenheimer maintained its Outperform rating and $165 price target. The target implies 17.6% upside from the Oct. 12 close of $140.32.
Oppenheimer Maintains Outperform Rating on Pulse Biosciences, Sets $60 Target
Oppenheimer maintained its Outperform rating on Pulse Biosciences and a $60 price target. The target implies 14.4% upside from the Oct. 12 close of $52.45.
Oppenheimer Maintains Outperform Rating on Nurix Therapeutics, $32 Target
Oppenheimer maintained its Outperform rating on Nurix Therapeutics with a $32.00 price target, implying 44.4% upside from the Oct. 12 close of $22.16.
Oppenheimer Maintains Outperform on Cheesecake Factory, $122 Price Target
Oppenheimer maintained its Outperform rating on The Cheesecake Factory stock with a price target of $122.00, implying an upside of 11.9% from the Oct 5 close.
Oppenheimer Maintains Outperform on Semtech, $225 Price Target
Oppenheimer maintained its Outperform rating on Semtech's stock and set a price target of $225, implying a 26.2% upside from the previous close. The analyst note highlighted strong growth prospects for the company.
Oppenheimer maintains Outperform on Sagimet Biosciences with $38 price target
Oppenheimer maintained its Outperform rating for Sagimet Biosciences, setting a price target of $38.00, which suggests a potential upside of 284.6% from its previous closing price.
Oppenheimer maintains Outperform rating on Jefferies Financial Gr, $71 price target
Oppenheimer maintained their Outperform rating on Jefferies Financial Gr's stock with a price target of $71.00.The price target implies an upside of 50.6% from the Sep 28 close of $47.13.Key takeaways from the analyst noteStrong Earnings Performance: Jefferies Financial Group reported earnings per…
AT&T Waives $10.3M Charges In Revised SurgePays Deal
AT&T Inc. (NYSE: T ) shares are trading slightly higher on Thursday after the company amended a wholesale agreement with SurgePays, Inc. (NASDAQ: SURG ). The move reads as a small relief bounce near the stock’s 52-week lows, even as the longer-term chart remains pressured. What Catalyst Is Driving AT&T’s Stock Movement